June 30, 2011


U.S. District Court Rules that Merial’s FRONTLINE Plus® Patent is valid

- Court orders seizure of existing PetArmor™ Plus products inventory in the U.S. -

 


U.S. District Court Rules that Merial’s FRONTLINE Plus® Patent is valid
- Court orders seizure of existing PetArmor™ Plus products inventory in the U.S. -

Paris, France – June 30, 2011 – Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. District Court for the Middle District of Georgia ruled that Merial’s U.S. patent covering FRONTLINE Plus® is valid and the PetArmor™ Plus products infringe the patent. Merial is a Sanofi company.